Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF ‐mutated colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF ‐mutated colorectal cancer

Published:2021-07-29 Issue:9 Volume:112 Page:3856-3870
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hiraide Sakura¹²,Takahashi Masanobu²³^ORCID,Yoshida Yuya¹²,Yamada Hideharu¹,Komine Keigo²³,Ishioka Chikashi¹²³^ORCID

Affiliation:

1. Department of Clinical Oncology Tohoku University Graduate School of Medicine Miyagi Japan

2. Department of Clinical Oncology Institute of Development, Aging and Cancer Tohoku University Miyagi Japan

3. Department of Medical Oncology Tohoku University Hospital Miyagi Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15075

Reference51 articles.

1. Mutations of the BRAF gene in human cancer

2. Tumor adaptation and resistance to RAF inhibitors

3. Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

4. New perspectives for targeting RAF kinase in human cancer

5. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF^V600E colorectal cancer;Cancer Science;2024-08-22

2. A novel miRNA‐based signature as predictive tool of survival outcome of colorectal cancer patients;Chemical Biology & Drug Design;2023-08-02

3. Exosomal miRNAs contribute to coal dust particle-induced pulmonary fibrosis in rats;Ecotoxicology and Environmental Safety;2023-01

4. Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;The Enzymes;2023

5. Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy;Cell Communication and Signaling;2022-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3